Nandu Thalange

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 3

Top Topics

Metabolic Syndrome

Cross Sectional

Replacement Therapy

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Pediatric diabetes

BMJ open diabetes research & care

Al Jalila Children's Specialty Hospital

King's College London (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Al Jalila Children's Specialty Hospital Aug 13 2017

United Arab Emirates

Consultant Paediatric Endocrinologist :: Endocrinology

Norfolk and Norwich University Hospital Apr 01 2002 - Apr 23 2017

United Kingdom

Consultant Paediatric Endocrinologist :: Jenny Lind Children's Department

Education History

King's College London

United Kingdom

BSC :: Medicine

Publications

Nandu Thalange, Torben Biester, Thomas Danne
Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (4) (2019)
Nandu Thalange, Jens Gundgaard, Witesh Parekh, Deniz Tutkunkardas
Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK. BMJ open diabetes research & care 7 (1) (2019)
Nandu Thalange, Larry Deeb, Georgeanna Klingensmith, Denise R Franco, Lars Bardtrum, Deniz Tutkunkardas, Thomas Danne
The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials. Pediatric diabetes 20 (3) (2019)